Men’s health, prostate diseases, stone disease, kidney transplant, urinary complaints and urological cancers are planned individually by evaluating the patient’s age, complaint, examination findings and necessary tests together.
Symptoms, examination and required tests are considered together.
The treatment pathway is adapted to the patient rather than using a single protocol.
You can use the online appointment form or the WhatsApp line.
Duration, sense of control, anxiety cycle and relationship dynamics are evaluated together.
Vascular status, hormones, metabolic factors, medications and psychosexual components are considered together.
Patient expectations, anatomical suitability and safe medical limits are kept at the forefront.
Urinary flow, nocturia, BPH and HoLEP suitability in selected patients are assessed individually.
PSA elevation, prostate enlargement, HoLEP, prostate cancer suspicion and biopsy decisions are evaluated within the same clinical framework.
PSA, examination, imaging and biopsy necessity are planned together.
Blood in the urine and risk factors require cystoscopy and further evaluation when appropriate.
For kidney, ureter and bladder stones, location, size and infection risk determine the treatment pathway.
Living donor evaluation, recipient preparation, pre-transplant urological assessment and post-transplant follow-up are planned together.
Robotic prostatectomy, sacrocolpopexy, partial nephrectomy, nephrectomy and robotic pyeloplasty are evaluated within minimally invasive surgical principles with correct patient selection.
Urinary incontinence, pelvic floor problems and functional complaints are evaluated comprehensively.
Biopsy planning is based on PSA, MRI findings and risk assessment.
HPV, genital warts, cryotherapy, CryoPen, vaccination and prevention are evaluated together.
